Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05410197
Status:
RECRUITING
Last Update Posted:
2022-10-12
First Post:
2022-06-04
Brief Title:
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line TreatmentENLIGHTEN
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Organization Data
Organization:
Sun Yat-sen University
Class:
OTHER
Study ID:
BTC2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Ming Kuang
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-sen University
Old Name:
None
Old Organization:
None